These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15071249)

  • 1. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial pacing therapies for prevention of atrial fibrillation in patients with implantable defibrillators.
    Gillis AM
    Card Electrophysiol Rev; 2003 Dec; 7(4):345-7. PubMed ID: 15071250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator.
    Ricci R; Pignalberi C; Santini M
    Card Electrophysiol Rev; 2003 Dec; 7(4):348-51. PubMed ID: 15071251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with implantable atrial and combined atrioventricular defibrillators.
    Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Schimpf R; Vahlhaus C; Welz A; Lüderitz B
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():185-95. PubMed ID: 10590507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator.
    Schwartzman D; Gold M; Quesada A; Koehler JL; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):708-13. PubMed ID: 16050827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.
    Euler DE; Friedman PA
    Card Electrophysiol Rev; 2003 Dec; 7(4):355-8. PubMed ID: 15071253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of induced and spontaneous atrial tachyarrhythmias in patients with a history of spontaneous atrial tachyarrhythmias.
    Wollmann CG; Birnie D; Tang A; Boriani G; Kühl M; Böcker D;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):818-22. PubMed ID: 16101621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1196-205. PubMed ID: 11083239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.
    Friedman PA; Dijkman B; Warman EN; Xia HA; Mehra R; Stanton MS; Hammill SC
    Circulation; 2001 Aug; 104(9):1023-8. PubMed ID: 11524396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.